The Effect of Ruboxistaurin Mesylate (LY333531) on Small Fiber Function as Measured by Microvascular Skin Blood Flow, C-Fiber Quantitations in Skin and Quantitative Sensory Testing of Cold and Heat.

NCT00190970 Phase 2 COMPLETED

To determine the effect of Ruboxistaurin on small fiber function.

Details

Lead sponsor	Chromaderm, Inc.
Phase	Phase 2
Status	COMPLETED
Enrolment	52
Start date	2004-10
Completion	2005-11

Conditions

• Diabetic Neuropathy

Interventions

• Ruboxistaurin

Primary outcomes

• The objectives of this study is to evaluate the effect of ruboxistaurin on subjects with diabetic peripheral polyneuropathy

Countries

United States